Inhibrx Biosciences amends loan agreement with Oxford Finance
The company amended its loan and security agreement to modify term loan commitments and provisions. This change adjusts the debt structure and borrowing options for the biological products developer.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed